Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03697304
Title Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours.
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Age Groups: senior | adult
Covered Countries USA | GBR | CAN

Facility Status City State Zip Country Details
University of California San Diego La Jolla California 92093 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Florida Cancer Specialists Saint Petersburg Florida 33705 United States Details
Florida Cancer Specialists Tallahassee Florida 32308 United States Details
Florida Cancer Specialists - East West Palm Beach Florida 33401 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Oklahoma University School of Community Medicine Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
Medical College Of Wisconsin Milwaukee Wisconsin 53226 United States Details
Cross Cancer Institute (University of Alberta) Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 1Z6 Canada Details
Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
University College Hospital London NW1 2BU United Kingdom Details
Guy's Hospital London SE1 9RT United Kingdom Details
Sarah Cannon Research Institute London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from for the field